The pharmaceutical 17α-ethynylestradiol (EE2) is considered as an endocrine-disrupting chemical that interferes with male reproduction and hormonal activation. In this study, we investigated the molecular mechanism underlying EE2-regulatory testosterone release in vitro and in vivo. The results show that EE2 treatment decreased testosterone release from rat Leydig cells. Treatment of rats with EE2 reduced plasma testosterone levels and decreased the sensitivity of human chorionic gonadotropin (hCG). EE2 reduced luteinizing hormone receptor (LHR) expression associated with decreased cAMP generation by downregulation of adenylyl cyclase activity and decreased intracellular calcium-mediated pathways. The expression levels of StAR and P450scc were decreased in Leydig cells by treatment of rats with EE2 for 7 days. The sperm motility in the vas deferens and epididymis was reduced, but the histopathological features of the testis and the total sperm number of the vas deferens were not affected. Moreover, the serum dihydrotestosterone (DHT) level was decreased by treatment with EE2. The prostate gland and seminal vesicle atrophied significantly, and their expression level of 5α-reductase type II was reduced after EE2 exposure. Taken together, these results demonstrate an underlying mechanism of EE2 to downregulate testosterone production in Leydig cells, explaining the damaging effects of EE2 on male reproduction.The endocrine system precisely mediates sexual development and reproductive ability through circulating sexual hormones, which act as signaling molecules to render adequate regulation. Endocrine-disrupting chemicals (EDCs) are natural or industrial chemicals that are released into the environment through industries, livestock activities, domestic wastewater, and hospital effluence 1,2 . Numerous studies have indicated that EDCs interfere with endogenous endocrine processes by mimicking hormonal action, leading to infertility, metabolic syndrome, and the rise of cancer incidence 3-5 . In humans, increasing studies have indicated that EDCs have detrimental effects on the reproductive system, resulting in poor sperm quality and testicular dysgenic occurrence in men 6,7 , and disorders of ovulation and the uterus as well as a rise in breast cancer incidences in women 8,9 . Hence, the risks of EDCs are a global health issue 10 .EE2 has been reported to exert a higher estrogenic activity than estradiol (E2), and is extremely stable against oxidation by metabolism or degradation in the human body due to the property of the ethynyl group in the C 17 position [11][12][13] . This characteristic potentially allows 17α-ethynylestradiol (EE2) to pass into the environment 14,15 . Therefore, it is reasonable to consider environmental EE2 to be an EDC and have deleterious effects on the health of both animals and human beings 15 . The pharmaceutical EE2 is a synthetic estrogen widely used as an oral contraceptive pill, but abundant animal studies have also reported that long-term exposure to EE2 interferes with the biological ...